The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Column Mid Cap CFMCX
- NAV / 1-Day Return 11.17 / +0.18 %
- Total Assets 879.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.490%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Mid-Cap Blend
- Investment Style Mid Blend
- Min. Initial Investment —
- Status Open
- TTM Yield —
- Turnover —
USD | NAV as of May 18, 2024 | 1-Day Return as of May 18, 2024, 12:32 AM GMT+0
Morningstar’s Analysis CFMCX
Will CFMCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 9.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
First American Government Obligs X | 2.59 | 22.9 Mil | Cash and Equivalents |
AMETEK Inc | 1.26 | 11.2 Mil | Industrials |
EUR/USD FWD 20240628 Purchased | 1.00 | 8.9 Mil | Derivative |
Ross Stores Inc | 0.98 | 8.7 Mil | Consumer Cyclical |
The Cooper Companies Inc | 0.97 | 8.6 Mil | Healthcare |
Houlihan Lokey Inc Class A | 0.95 | 8.4 Mil | Financial Services |
Monolithic Power Systems Inc | 0.92 | 8.2 Mil | Technology |
West Pharmaceutical Services Inc | 0.92 | 8.1 Mil | Healthcare |
Equifax Inc | 0.86 | 7.6 Mil | Industrials |
Cencora Inc | 0.84 | 7.4 Mil | Healthcare |